Predictive value of vascular endothelial growth factor receptor type 2 in triple-negative breast cancer patients treated with neoadjuvant chemotherapy
Crossref DOI link: https://doi.org/10.1007/s11010-017-3244-1
Published Online: 2017-12-11
Published Print: 2018-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Babyshkina, Nataliya http://orcid.org/0000-0002-0562-3878
Zavyalova, Marina
Tarabanovskaya, Natalia
Dronova, Tatyana
Krakhmal, Nadejda
Slonimskaya, Elena
Kzhyshkowska, Julia
Choynzonov, Evgeny
Cherdyntseva, Nadejda
License valid from 2017-12-11